Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-11, Stock:LLY, The news for the past five days is as follows:
2019-03-04: NEWS1: After Hours Most Active for Mar 4, 2019 :  LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS.NEWS2: After Hours Most Active for Mar 4, 2019 :  LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS.NEWS3: Monday's ETF with Unusual Volume: PWB.NEWS4: Monday's ETF with Unusual Volume: PWB.NEWS5: Lilly to sell cheaper version of top-selling insulin Humalog.NEWS6: Lilly to sell cheaper version of top-selling insulin Humalog.NEWS7: Eli Lilly seeks to quell drug price anger with cheaper insulin.NEWS8: Eli Lilly Is Cutting the Price of a Key Drug By 50%.NEWS9: Cheaper Insulin Is a Big Victory for Patients.NEWS10: Eli Lilly Stock Drops After Launching Cheaper Version of Top-Selling Insulin.NEWS11: Eli Lilly announces cheaper, generic version of insulin.NEWS12: Eli Lilly seeks to quell drug price anger with cheaper insulin.NEWS13: Stocks making the biggest moves premarket: Tesla, AT&T, Eli Lilly & more.NEWS14: What are AstraZeneca’s Key Growth Drivers?.NEWS15: [$$] Lilly to launch generic version of insulin at steep discount.NEWS16: Eli Lilly to make generic insulin available at half of Humalog's current price.NEWS17: Lilly to introduce lower-priced insulin injection.NEWS18: Lilly to Introduce Lower-Priced Insulin.
2019-03-05: NEWS1: Eli Lilly to offer half-price version of insulin amid Trump’s pressure to lower drug prices.NEWS2: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS3: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS4: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS5: Eli Lilly will offer a half-off version of its popular insulin drug Humalog.NEWS6: Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults.NEWS7: Drugmaker Eli Lilly cutting price of popular insulin Humalog.
2019-03-06: NEWS1: After Hours Most Active for Mar 6, 2019 :  GE, LLY, WBA, WRE, BAC, V, SHY, S, SBUX, AAPL, QQQ, PACB.NEWS2: After Hours Most Active for Mar 6, 2019 :  GE, LLY, WBA, WRE, BAC, V, SHY, S, SBUX, AAPL, QQQ, PACB.NEWS3: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS4: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS5: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS6: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS7: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS8: 3 Big Pharmas Trying to Pop the Rebate Bubble.NEWS9: 3 Big Pharmas Trying to Pop the Rebate Bubble.NEWS10: FDA Approves Major Novel Depression Drug For First Time In 3 Decades.NEWS11: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS12: 3 Big Pharmas Trying to Pop the Rebate Bubble.NEWS13: See what the IHS Markit Score report has to say about Eli Lilly and Co..
2019-03-07: NEWS1: Lilly to Participate in Cowen Health Care Conference.NEWS2: Notable Thursday Option Activity: LLY, KR, EIX.NEWS3: Notable Thursday Option Activity: LLY, KR, EIX.NEWS4: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS5: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS6: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS7: Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer.
2019-03-08: NEWS1: After Hours Most Active for Mar 8, 2019 :  LLY, PFE, ORCL, MRO, JD, QQQ, EBAY, T, GE, URBN, MSFT, IEF.NEWS2: After Hours Most Active for Mar 8, 2019 :  LLY, PFE, ORCL, MRO, JD, QQQ, EBAY, T, GE, URBN, MSFT, IEF.NEWS3: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS4: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS5: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS6: Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat.NEWS7: Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat.NEWS8: Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?.NEWS9: Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?.NEWS10: PWB, PWC: Big ETF Outflows.NEWS11: PWB, PWC: Big ETF Outflows.NEWS12: Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat.NEWS13: Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?.NEWS14: Pre-Market Most Active for Mar 8, 2019 :  LLY, TNXP, SQQQ, TVIX, NIO, CHK, ALT, BJ, SBGL, ACB, QQQ, AMD.NEWS15: Pre-Market Most Active for Mar 8, 2019 :  LLY, TNXP, SQQQ, TVIX, NIO, CHK, ALT, BJ, SBGL, ACB, QQQ, AMD.NEWS16: Lilly to Participate in Barclays Global Healthcare Conference.

Answer: Decrease